11 Crazy Valuable Vintage Apple Products and Collectibles

Apple products aren’t cheap. Take for instance the iPhone X (up to $ 1,149) or the iMac Pro which can fetch over $ 13,000! That’s a lot of money, but I’m sure you can imagine that vintage Apple products can be even more expensive. Do you know which Apple Computer sold for almost $ 1,000,000? Use the right arrow to browse this list of crazy expensive Apple collectibles to find out.

iDrop News

Here’s What We Know About the Crazy New Startup Where Scientists Use Crypto to Buy Your Genetic Data

If innovators have their way, you’ll soon start seeing blockchain beyond the realm of cryptocurrency. People have been thinking creatively about how to use the technology powering Bitcoin to do things like shake up how people vote or access their birth records.

Now, pioneering Harvard and MIT geneticist George Church (of CRISPR and mammoth-resurrection fame) has a new startup that plans to use blockchain technology for genome sequencing — but it’s not yet clear whether it will be popular enough to edge out the competition.

The startup, dubbed Nebula Genomics, seeks to change how companies handle an individual’s DNA. Though companies like 23andMe have become popular and thousands of people have gotten their genomes tested for things like their ancestry and health conditions they might pass on to their children, most people still haven’t had their DNA sequenced. Some of the reasons may be that the test is still fairly pricey, plus consumers aren’t assured much privacy in doing so.

That’s where Nebula thinks it can do better — consumer-patients can get paid for submitting their genomic information, and ensure it’s safe in the process, according to a white paper the company recently published.

Here’s what we know about Nebula’s plans so far. It’s simple, until it’s not:

  1. Companies like 23andMe and AncestryDNA are “middlemen,” acquiring people’s DNA, then selling it to pharmaceutical and research companies for millions of dollars. Nebula wants to eliminate them. In their place, DNA/data owners will interface directly with DNA/data buyers. There will be no “middlemen,” as Nebula puts it.
  2. Nebula will sequence the DNA itself, but it’ll be pricey, at least at first. Sequencing a single person’s DNA will start at $ 1,000, though Nebula expects it to drop to less than $ 100 “in a few years.”
  3. Owners don’t have to sell their information. After a person gets their results from Nebula, an app will allow them to “interpret their personal genomic data without sharing it with any third party.” As the app analyzes more DNA sequences, the information available to consumers will become more comprehensive.
  4. All data will be privately stored on Nebula’s network. Initial access is granted only to the owner, though they can give others access to it as well. Owners can also choose to store their data wherever they want, including on Dropbox.
  5. Organizations that want to buy users’ DNA have to be upfront about who they are, and all transactions will be recorded on the Nebula blockchain. It’s unclear if real names are required, or if something like “DNA_Enthusiast93” will suffice.
  6. Nebula tokens will be the sole currency on the network. Individuals use Nebula tokens to pay Nebula for their personal genome sequencing. Entities looking to buy genomic data will pay tokens to gain access to genome sequences, purchased with traditional currency. Interestingly, Nebula acknowledges that the value of Nebula tokens will decrease as DNA sequencing becomes cheaper. It’s still pretty unclear what this would mean for the network, or how exactly people will exchange tokens.
  7. Buyers, such as pharmaceutical companies or academics, can conduct surveys targeted at DNA owners and provide Nebula tokens in exchange. These buyers can also offer to pay an individual’s genome sequencing cost if the survey reveals information that is particularly interesting to the buyer.

Given the way genome sequencing industry currently works, integrating blockchain seems pretty revolutionary. But Nebula isn’t so unique, in fact— other startups such as EncrypGen, Luna DNA, and Zenome have indicated that they might build platforms for people to sell their own DNA, as Tech Crunch notes. The company won’t officially launch until later this year, giving the competition plenty of time to catch up.

A harder question to answer: will people trust paying with Nebula tokens? As STAT News points out, both bitcoin and Ripple have experienced sizable drops in their respective values in 2018, and bitcoin’s might even fall farther. The idea of investing in a new cryptocurrency that comes with an expiration date may be a hard sell.

And Nebula has some steep competition. Tests from 23andMe are popular, and incredibly simple (just give them your spit). The affordable $ 80 – $ 160 price is just low enough to seem worth it.

The post Here’s What We Know About the Crazy New Startup Where Scientists Use Crypto to Buy Your Genetic Data appeared first on Futurism.


$1,000 iPhone X was called crazy – now people are worried iPhone prices won’t keep rising

iPhone X Price

Talk about “damned if you do, damned if you don’t.” Apple unveiled the tenth-anniversary iPhone X last September, and people lost their minds when the company said it would charge $ 999 for the entry-level model and a whopping $ 1,149 for the version with 256GB of storage. Despite the prominence of smartphone financing plans in the United States and several other top smartphone markets around the world, some industry watchers were appalled, and they said a price tag above $ 1,000 was far too much to charge for the redesigned iPhone.

Apple doesn’t break down its iPhone sales by model, so we’ll never know exactly how many iPhone X units were sold during the holiday quarter. We’ll certainly get a few hints when Apple reports its holiday-quarter results on Thursday, particularly when analysts begin to dissect iPhone unit sales and ASPs. Ahead of Apple’s earnings report though, one industry watcher has expressed concern about Apple’s future performance. Doom and gloom is nothing new for Apple, of course, but one point in the analyst’s note is of particular interest: After all the hubbub Apple’s $ 1,000+ iPhone X caused, there are now worries that Apple’s iPhones prices will not continue to rise.

With just a day to go until Apple reports its fiscal first-quarter earnings, everyone seems to be coming out of the woodwork with a hot take. We’ve covered a few different points of view, and now the latest comes from BMO Capital Markets analyst Tim Long.

Long isn’t overly concerned with Apple’s holiday quarter and instead looks ahead to the March quarter, where he sees trouble brewing. “We expect a meaningful guide lower when the company reports on Thursday night, on the order of $ 5-6 billion compared to consensus revenue estimates,” the analyst wrote in a note to clients seen by BGR.

The Street’s consensus for Apple’s fiscal second-quarter revenue guidance is currently about $ 45.5 billion, and Long had issued a $ 46 billion estimate. He has now revised that guess down to just $ 39.9 billion for the March quarter, which cutting his rating on Apple shares to Market Perform from his earlier Outperform rating. Beyond the second quarter, Long sees problems down the road, largely because Apple will not continue to increase the price of its iPhones, which means ASPs won’t continue to climb.

“Following 10 years where ASPs have generally moved higher, we believe prices will plateau as with the rest of the industry,” Long wrote.

He continued, “Apple has done a good job of moving ASPs higher despite others in the industry flat-lining. We estimate that about 30% of iPhones will be priced over $ 900 this year, but we do not expect this figure to go any higher, particularly as only 12% of smartphones globally sell for over $ 600.”

Of note, Apple is widely expected to release three new iPhone models this September, including a larger “iPhone X Plus” that is priced higher than Apple’s current iPhone X model. While Long makes no mention of it, he apparently isn’t impressed with what he’s heard about Apple’s 2018 iPhone lineup so far.

“We still view the iPhone base as growing, and the devices are on average getting older. However, without a compelling product cycle in September, we may see a slow upgrade cycle once again,” the analyst wrote. “The recent stock reaction reminds us of early 2016, but later that year many investors started looking towards OLED and the 10-year anniversary phone, which drove the stock higher. No such product is on the horizon now.”

Long also believes Apple won’t see any growth this year in the key China market, and he revised his full-year revenue estimate down to $ 161 billion from his earlier $ 176.88 billion estimate.

Apple – BGR

Nest’s co-founder helped design this crazy concept smartwatch

Luxury watchmaker Ressence has a new prototype watch it’s showing off at the SIHH 2018 watch show (Salon International de la Haute Horlogerie, in case you were curious) called the Type 2 e-Crown Concept, as reported by Hodinkee. While it’s not quite a retail product just yet, it looks like the company may have figured out how to bring the disparate worlds of mechanical watches and smartwatches together.

Ever since smartwatches first became popular, traditional watchmakers have struggled to adjust to the new internet-connected landscape that devices like the Pebble, Apple Watch, and Android Wear created. We’ve seen a variety of approaches over the years to try to bridge that gap, with things like Montblanc’s e-Strap idea that stuck a…

Continue reading…

The Verge – All Posts